Skip to main content

Massive Perivillous Fibrinoid Deposition and Maternal Floor Infarct

  • Chapter
  • First Online:
Pathology of the Placenta

Abstract

Massive perivillous fibrinoid deposition (MPVFD) and maternal floor infarct (MFI) are part of a spectrum of lesion in which fibrinoid material is laid down between chorionic villi. These lesions can be recurrent and are associated with fetal growth restriction and, when severe, intrauterine fetal demise.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nelson DM, Crouch EC, Curran EM, Farmer DR. Trophoblast interaction with fibrin matrix: epithelialization of perivillous fibrin deposits as a mechanism for villous repair in the human placenta. Am J Pathol. 1990;136:855–65.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Vernof KK, Benirschke K, Gail M, et al. Maternal floor infarction: relationship to X-cells, major basic protein and adverse perinatal outcome. Am J Obstet Gynecol. 1992;167:1355–63.

    Article  CAS  Google Scholar 

  3. Katzman PJ, Genest DR. Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk or recurrence. Pediatr Dev Pathol. 2002;5:159–64. Erratum 2002;6:102

    Article  Google Scholar 

  4. Naeye RL. Maternal floor infarction. Hum Pathol. 1985;16:823–8.

    Article  CAS  Google Scholar 

  5. Andres RL, Kuyper W, Resnik R, et al. The association of maternal floor infarction of the placenta with adverse perinatal outcome. Am J Obstet Gynecol. 1990;163:935–8.

    Article  CAS  Google Scholar 

  6. Bane AL, Gillan JE. Massive perivillous fibrinoid causing recurrent placental failure. BJOG. 2003;110:292–5.

    Article  CAS  Google Scholar 

  7. Fuke Y, Aono T, Imai S, et al. Clinical significance and treatment of massive intervillous fibrin deposition associated with recurrent fetal growth retardation. Gynecol Obstet Investig. 1994;38:5–9.

    Article  CAS  Google Scholar 

  8. Faye-Petersen OM, Ernst LM. Maternal floor infarction and massive perivillous fibrin deposition. Surg Pathol Clin. 2013;6:101–14.

    Article  Google Scholar 

  9. Yu W, Tellier R, Wright JR Jr. Coxsackie virus A16 infection of placenta with massive perivillous fibrin deposition leading to intrauterine fetal demise at 36 weeks gestation. Pediatr Dev Pathol. 2015;18:331–4.

    Article  Google Scholar 

  10. Ordi J, Ismail MR, Ventura PJ, et al. Massive chronic intervillositis of the placenta associated with malaria infection. Am J Surg Pathol. 1998;22:1006–11.

    Article  CAS  Google Scholar 

  11. Bendon RW, Hommel AB. Maternal floor infarction in autoimmune disease: two cases. Pediatr Pathol Lab Med. 1996;16:293–7.

    Article  CAS  Google Scholar 

  12. Katz VL, Bowes WA Jr, Sierkh AE. Maternal floor infarction of the placenta associated with elevated second trimester maternal serum feto-protein. Am J Perinatol. 1987;4:225–8.

    Article  CAS  Google Scholar 

  13. Uxa R, Baczyk D, Kingdom JCP, et al. Genetic polymorphisms in the fibrinolytic system of placentas with massive perivillous fibrin deposition. Placenta. 2010;31:499–505.

    Article  CAS  Google Scholar 

  14. Pediatr Pathol Devisme L, Chauvière C, Franquet-Ansart H, et al. Perinatal outcome of placental massive perivillous fibrin deposition: a case-control study. Prenat Diagn. 2017;37:323–8.

    Article  Google Scholar 

  15. Griffin AC, Strauss AW, Bennett MJ, Ernst LM. Mutations in long-chain 3-hydroxyacyl coenzyme a dehydrogenase are associated with placental maternal floor infarction/massive perivillous fibrin deposition. Pediatr Dev Pathol. 2012;15:368–74.

    Article  Google Scholar 

  16. Sebire NJ, Backos M, Goldin RD, Regan L. Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. Br J Obstet Gynaecol. 2002;109:570–3.

    Article  CAS  Google Scholar 

  17. Matern D, Schehata BM, Shekhawa P, et al. Placental floor infarction complicating the pregnancy of a fetus with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. Mol Genet Metab. 2001;72:265–8.

    Article  CAS  Google Scholar 

  18. Whitten AE, Romero R, Korzeniewski SJ, et al. Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death. Am J Obstet Gynecol. 2013;208:310.e1–310.e11.

    Article  CAS  Google Scholar 

  19. Linn RL, Kiley J, Minturn L, et al. Recurrent massive perivillous fibrin deposition in the placenta associated with fetal renal tubular dysgenesis: case report and literature review. Pediatr Dev Pathol. 2013;16:378–86.

    Article  Google Scholar 

  20. Romero R, Whitten A, Korzeniewski SJ, et al. Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection. Am J Reprod Immunol. 2013;70:285–98.

    Article  CAS  Google Scholar 

  21. Adams-Chapman I, Vaucher YE, Bejar RF, et al. Maternal floor infarction of the placenta: association with central nervous system injury and adverse neurodevelopmental outcome. J Perinatol. 2002;22:236.

    Article  Google Scholar 

  22. Benirschke K, Driscoll SG. The pathology of the human placenta. New York: Springer-Verlag; 1967.

    Google Scholar 

  23. Abdulghani S, Moretti F, Gruslin A, Grynspan D. Recurrent massive perivillous fibrin deposition and chronic intervillositis treated with heparin and intravenous immunoglobulin: a case report. J Obstet Gynaecol Can. 2017;39:676–81.

    Article  Google Scholar 

  24. Chaiworapongsa T, Romero R, Korzeniewski SJ, et al. Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD). J Matern Fetal Neonatal Med. 2016;29:855–62.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philip J. Katzman .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Katzman, P.J., Ernst, L.M., Scheimberg, I.B. (2019). Massive Perivillous Fibrinoid Deposition and Maternal Floor Infarct . In: Khong, T., Mooney, E., Nikkels, P., Morgan, T., Gordijn, S. (eds) Pathology of the Placenta. Springer, Cham. https://doi.org/10.1007/978-3-319-97214-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-97214-5_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-97213-8

  • Online ISBN: 978-3-319-97214-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics